A 5′ regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells

被引:30
|
作者
Petrella, A
Doti, I
Agosti, V
Giarrusso, PC
Vitale, D
Bond, HM
Cuomo, C
Tassone, P
Franco, B
Ballabio, A
Venuta, S
Morrone, G
机构
[1] CEINGE Adv Biotechnol, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy
[2] Fac Med, Dept Expt & Clin Med, Catanzaro, Italy
[3] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy
[4] Telethon Inst Genet & Med, Milan, Italy
[5] Ist Nazl Tumori Fdn Pascale, Naples, Italy
关键词
D O I
10.1182/blood.V91.12.4554.412k26_4554_4560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recently-identified Wiskott-Aldrich syndrome protein gene (WASP) is responsible fbr the Wiskott-Aldrich X-linked immunodeficiency as well as for isolated X-linked thrombocytopenia (XLT). To characterize the regulatory sequences of the WASP gene, we have isolated, sequenced and functionally analyzed a 1.6-Kb DNA fragment upstream of the WASP coding sequence. Transfection experiments showed that this fragment is capable of directing efficient expression of the reporter chloramphenicol acetyltransferase (CAT) gene in all human hematopoietic cell lines tested. Progressive 5' deletions showed that the minimal sequence required for hematopoietic-specific expression consists of 137 bp upstream of the transcription start site. This contains potential binding sites for several hematopoietic transcription factors and, in particular, two Ets-1 consensus that proved able to specifically bind to proteins present in nuclear extracts of Jurkat cells. Overexpression of Ets-1 in HeLa resulted in transactivation of the CAT reporter gene under the control of WASP regulatory sequences. Disruption of the Ets-binding sequences by side-directed mutagenesis abolished CAT expression in Jurkat cells, indicating that transcription factors of the Ets family play a key role in the control of WASP transcription. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:4554 / 4560
页数:7
相关论文
共 50 条
  • [31] X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP)
    Luthi, JN
    Gandhi, MJ
    Drachman, JG
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (02) : 150 - 158
  • [32] Deletion of Wiskott-Aldrich Syndrome Protein in Regulatory T-Cells Results in Spontaneous Allergic Sensitization to Food
    Lexmond, Willem S.
    Goettel, Jeremy A.
    Snapper, Scott B.
    Fiebiger, Edda
    GASTROENTEROLOGY, 2014, 146 (05) : S828 - S828
  • [33] DEFICIENCY OF REGULATORY B CELLS IN WISKOTT-ALDRICH SYNDROME PROTEIN DEFICIENT MICE LEADS TO EXACERBATED AUTOIMMUNE ARTHRITIS
    Bouma, G.
    Carter, N. A.
    Recher, M.
    Notarangelo, L. D.
    Burns, S. O.
    Mauri, C.
    Thrasher, A. J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 12 - 12
  • [34] Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein
    Toscano, Miguel G.
    Frecha, Cecilia
    Benabdellah, Karim
    Cobo, Marien
    Blundell, Mike
    Thrasher, Adrian J.
    Garcia-Olivares, Enrique
    Molina, Ignacio J.
    Martin, Francisco
    HUMAN GENE THERAPY, 2008, 19 (02) : 179 - 197
  • [35] Persistent Multilineage Engraftment and WASP Restored Expression After Lentiviral Mediated CD34+Cells Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome
    Scaramuzza, S.
    Giannelli, S.
    Ferrua, F.
    Castiello, M. C.
    Cicalese, M. P.
    Assanelli, A.
    Biasco, L.
    Ottaviano, G.
    Casiraghi, M.
    Bosticardo, M.
    Rizzardi, P.
    Finocchi, A.
    Metin, A.
    Albert, M.
    Petrescu, C.
    Banerjee, P. P.
    Orange, J. S.
    Biffi, A.
    Ciceri, F.
    Villa, A.
    Roncarolo, M. G.
    Naldini, L.
    Aiuti, A.
    MOLECULAR THERAPY, 2014, 22 : S88 - S88
  • [36] Expression of human Wiskott-Aldrich syndrome protein in patients' primary hematopoietic cells and EBV-transduced cell lines after retroviral vector-mediated gene transduction.
    Huang, MM
    Wong, A
    Weinberg, KI
    Francke, U
    Kohn, DB
    BLOOD, 1997, 90 (10) : 1154 - 1154
  • [37] Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins
    Huang, MM
    Tsuboi, S
    Wong, A
    Yu, XJ
    Oh-Eda, M
    Derry, JM
    Francke, U
    Fukuda, M
    Weinberg, KI
    Kohn, DB
    GENE THERAPY, 2000, 7 (04) : 314 - 320
  • [38] Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome
    Astrakhan, Alexander
    Sather, Blythe D.
    Ryu, Byoung Y.
    Khim, Socheath
    Singh, Swati
    Humblet-Baron, Stephanie
    Ochs, Hans D.
    Miao, Carol H.
    Rawlings, David J.
    BLOOD, 2012, 119 (19) : 4395 - 4407
  • [39] Lentiviral Vectors Targeting WASp Expression to Hematopoietic Cells, Efficiently Transduce CD34+ Cells and Correct Functions of Lymphocytes and Dendritic Cells from Wiskott-Aldrich Syndrome Patients
    Charrier, Sabine
    Dupre, Loic
    Scaramuzza, Samantha
    Jeanson, Laurence
    Blundell, Mike
    Danos, Olivier
    Cattaneo, Federica
    Aiuti, Alessandro
    Thrasher, Adrian
    Roncarolo, Maria-Grazia
    Galy, Anne
    MOLECULAR THERAPY, 2006, 13 : S259 - S259
  • [40] Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells
    Adriani, Marsilio
    Jones, Krysten A.
    Uchiyama, Toru
    Kirby, Martha R.
    Silvin, Christopher
    Anderson, Stacie M.
    Candotti, Fabio
    BLOOD, 2011, 117 (24) : 6608 - 6611